As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Featured article: Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was sent to 4458 dialysis facilities at the end of 2018; among these facilities, 4402 facilities (98.7%) responded to the facility questionnaire, and 4222 (94.7%) responded to the patient questionnaire.
Featured article: A new insight into the treatment of renal anemia with HIF stabilizer
The long-term clinical experiences with recombinant human erythropoietin (rHuEPO) and its analog derivatives have clearly proven that correction of anemia with erythropoiesis stimulating agent (ESA) not only reduces blood transfusion and improves patients’ QOL but has multiple benefits for the concurrent complications of CKD such as Cardio-Renal–Anemia (CRA) syndrome and/or malnutrition-inflammation-atherosclerosis (MIA) syndrome.
Featured article: Association between modified simple protein-energy wasting (PEW) score and all-cause mortality in patients receiving maintenance hemodialysis
Protein-energy wasting (PEW) is a frequently observed complication that leads to increased mortality in hemodialysis patients. However, a multifaceted assessment of PEW by combined objective nutritional parameters has not yet been established.
Articles
-
-
Predicting factors of intradialytic hypotension in the last half of hemodialysis therapy
-
Characteristics of adrenal insufficiency in hemodialysis patients
-
Triple combination therapy with telmisartan, amlodipine, and hydrochlorothiazide ameliorates albuminuria in a normotensive rat remnant kidney model
-
Efficacy and safety of plasma hemodiafiltration (PHDF) in pediatric patients with multiple organ dysfunction syndrome with shock and DIC: a preliminary study
2019
Thematic series
Official Guideline and Registry Data of Renal Replacement Therapy
Upcoming conferences
The 66th Annual Meeting of the Japanese Society for Dialysis Therapy
4-6 June 2021, Pacifico Yokohama
The 67th Annual Meeting of the Japanese Society for Dialysis Therapy
30 June - 2 July 2022, Pacifico Yokohama
The 32nd Annual Meeting of the Japan Society for Blood Purification Critical Care
2-3 October 2021, Rafre Saitama
The 33rd Annual Meeting of the Japan Society for Blood Purification Critical Care
7-8 October 2022, Juroku Plaza
The 11th Annual Meeting of the Japanese Society of Renal Rehabilitation
20-21 March 2021, Live On demand from 29 March 2021 to April 30 2021
The 27th Annual Meeting of the Japanese Society for Peritoneal Dialysis
30-31 October 2021, TORANOMON HILLS FORUM
The 15th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
11-12 November 2021, Pacifico Yokohama
The 16th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
29-30 October 2022, DEJIMA MESSE NAGASAKI
The 24th Annual Meeting of Japan Academy of Nephrology Nursing
13-14 November, 2021, FUKUOKA CONVENTION CENTER
The 42nd Japanese Society for Pediatrics Renal Failure
9-10 December, 2021, Osaka City Central Public Hall
The 43nd Japanese Society for Pediatrics Renal Failure
24-25 November, 2022, Yumoto Fujiya Hotel
The 54th Annual Meeting of Japanese Society for Clinical Renal Transplantation
17-19 February 2021, Live On demand from 20 February 2021 to 19 March 2021
The 55th Annual Meeting of Japanese Society for Clinical Renal Transplantation
23-25 February 2022
The 12th Annual Meeting of the Japanese Society of Renal Rehabilitation
26-27 March 2022, Okayama Convention Center
The 13th Annual Meeting of the Japanese Society of Renal Rehabilitation
17-19 March 2023, Omiya Sonic City Hall
Submit your manuscript
Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.
Aims and scope
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
Overcoming Language Barriers
If your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.
Society affiliations
Renal Replacement Therapy is the official publication of the following societies:
- Japanese Society for Dialysis Therapy (JSDT)
- Japanese Society for Clinical Renal Transplantation (JSCRT)
- Japanese Society for Peritoneal Dialysis (JSPD)
- Japan Society for Blood Purification in Critical Care (JSBPCC)
- Japanese Society of Renal Rehabilitation (JSRR)
- Japanese Society of Nephrology and Pharmacotherapy (JSNP)
- Japanese Society for Pediatric Renal Failure (JSPRF)
- Japan Academy of Nephrology Nursing (JANN)
About the Editor
Dr. Takashi Shigematsu, Editor-in-Chief
Dr. Takashi Shigematsu is currently the emeritus professor of the department of nephrology at the Wakayama Medical University School of Medicine, Japan. He is now actively working as Director of Division of Nephrology and Clinical Research Center in Rinku General Medical Center. He is also a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on Mineral and Bone Disorder associated with chronic kidney disease (CKD) including vascular calcification, Senescence. Renal Anemia is another his major interest. In addition, he has been investigating and working in the fields of hemodialysis and vascular access, peritoneal dialysis, blood purification medicine in acute kidney injury, and kidney transplantation.
Annual Journal Metrics
-
Speed
42 days to first decision for reviewed manuscripts only
38 days to first decision for all manuscripts
141 days from submission to acceptance
19 days from acceptance to publication
Usage
276,989 Downloads
13 Altmetric mentions
